Pacira Biosciences, Inc. (PCRX)
22.64
-0.89
(-3.78%)
USD |
NASDAQ |
May 15, 16:00
22.62
-0.02
(-0.07%)
After-Hours: 20:00
Pacira Biosciences Market Cap : 890.84M for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 6.051B |
| Bristol Myers Squibb Co. | 116.40B |
| Assertio Holdings, Inc. | 149.64M |
| Johnson & Johnson | 545.74B |
| Eli Lilly & Co. | 896.13B |
Market Cap Related Metrics
| PE Ratio | 181.12 |
| PS Ratio | 1.339 |
| Price to Book Value | 1.362 |
| Price to Free Cash Flow | 7.413 |
| Price | 22.64 |
| Earnings Yield | 0.55% |
| Operating PE Ratio | 39.51 |
| Normalized PE Ratio | 158.32 |